Denali Therapeutics Inc
NASDAQ:DNLI
Denali Therapeutics Inc
NASDAQ:DNLI
Price:
20.77 USD
-2.53%
Market Closed
Updated:
Jun 9, 2024
Denali Therapeutics Inc
Other Non-Cash Items
|
Denali Therapeutics Inc
Other Non-Cash Items Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Denali Therapeutics Inc
NASDAQ:DNLI
|
Other Non-Cash Items
$42.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Non-Cash Items
$7.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
29%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Non-Cash Items
$8.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
35%
|
CAGR 10-Years
37%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Non-Cash Items
$1.8B
|
CAGR 3-Years
157%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Non-Cash Items
$585.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
110%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Denali Therapeutics Inc's Other Non-Cash Items?
Other Non-Cash Items
42.9m
USD
42.9m
USD
Based on the financial report for Mar 31, 2024, Denali Therapeutics Inc's Other Non-Cash Items amounts to 42.9m USD.
What is Denali Therapeutics Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
16%
16%
Over the last year, the Other Non-Cash Items growth was -51%. The average annual Other Non-Cash Items growth rates for Denali Therapeutics Inc have been -11% over the past three years , 16% over the past five years .
You don't have any saved screeners yet
